Medicare Home Infusion Therapy Coverage Act of 2009

DME Competitive Bidding, H.R. 5597: To Establish a Medicare Patient IVIG Access Demonstration Project, H.R. 574: Medicare Home Infusion Therapy Coverage Act of 2009, Medicare Coverage of Diabetic Testing Supplies

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

Client expense: $509,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

Client expense: $389,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

Client expense: $389,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of

Home Oxygen Reimbursement, S. 254/H.R.574: Medicare Home Infusion Therapy Coverage Act of 2009, DME Competitive Bidding, Medicare Audits: Waste, Fraud, and Abuse, H.R. 5712: The Physician Payment and Therapy Relief Act, H.R. 4994: The Medicare and Medicaid Extenders Act of 2010

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

DME Competitive Bidding, H.R. 5597: To Establish a Medicare Patient IVIG Access Demonstration Project, H.R. 574: Medicare Home Infusion Therapy Coverage Act of 2009, Medicare Coverage of Diabetic Testing Supplies

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3790: Medicare Competitive Bidding for DMEPOS S. 254/H.R. 574: Medicare Home Infusion Therapy Coverage Act of 2009

Client expense: $160,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage Issues H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009 H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) P.L. 111-148 Patient Protection and Affordable Care Act implementation P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital and "Pay to Delay" Provisions) S. 3677 Financial Services and General Government Appropriations Act, 2011 (Pay to Delay Provision) S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011(Infectious Disease Provisions) H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-317 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290 H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 (340B provisions) H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286 (340B provisions)

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage Issues H.R.574 Medicare Home Infusion Therapy Coverage Act of 2009 S.254 Medicare Home Infusion Therapy Coverage Act of 2009 H.R.3081 Continuing Appropriations Act, 2011 (340B Provisions) P.L.111-148 Patient Protection and Affordable Care Act implementation P.L.111-152 Health Care and Education Reconcilliation Act of 2010 implementation S.11 To restore the application of the 340B drug discount program to orphan drugs with respect to children's hospitals H.R.5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Children's Hospital and "Pay to Delay" Provisions) S.3677 Financial Services and General Government Appropriations Act, 2011 ("Pay to Delay" Provision) S.3686 Labor, Healtha nd Human Services, and Education Appropriations Act, 2011 (Infectious Disease Provisions) H.R.3082 Continuing Appropriations and Surface Transporation Extensions Act, 2011; P.L.111-322 H.J.RES.105 Making further continuation appropriations for fiscal year 2011, and for other purposes; P.L.111-317 H.J.RES.101 Making further continuation appropriations for fiscal year 2011, and for other purposes; P.L.111-290 H.R.4994 Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 (340B provisions) H.R.5712 The Physicians Payment and Therapy Relief Act of 2010; P.L.111-286 (340B provisions)

Client expense: $210,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)

H.R. 574, Medicare Home Infusion Therapy Coverage Act of 2009. A bill to amend title XVIII of the Social Security Act to provide for the coverage of home infusion therapy under the Medicare Program. S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. A bill to amend title XVIII of the Social Security Act to provide for the coverage of home infusion therapy under the Medicare Program.

Client expense: $43,881 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Healthcare reform; healthcare regulations; Medicare Part D; proposed antitrust exemptions for certain pharmacies; IVIG payments; Medicare demonstration projects for durable medical equipment; importation of prescription drugs; home infusion; disclosure of PBM information; changes to drug benefits offered under the FEHBP and increasing healthcare value; competitive bidding; proposed revisions to the blood glucose local coverage determination H.R. 574 and S. 254 - Medicare Home Infusion Therapy Coverage Act of 2009; all sections H.R. 1204 - Community Pharmacy Fairness Act of 2009; all sections H.R. 1765 - To Amend Title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program; all sections H.R. 5597 - To Establish a Medicare Patient IVIG Access Demonstration Project; all sections H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009; all sections H.R. 3962 - Affordable Healthcare for All America Act of 2009; all sections S. 1796 - America's Healthy Future Act of 2009; sections 1001 - 2221 H.R. 3790 - To amend Title XVIII of the Social Security Act to repeal the Medicare Competitive Acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS); all sections H.R. 4752 - Medicare Prescription Drug Price Negotiations Act of 2010; all sections Public Law 111-152 - Healthcare and Education Reconciliation Act of 2010 (formerly H.R. 4872); all sections

Client expense: $470,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), Postal Rate Commission, Postal Regulatory Commission, SENATE, U.S. Postal Service (USPS)

HR 1128: Liver Research Enhancement Act HR 1189: Colorectal Cancer Prevention, Early Detection and Treatment Act HR 745: Pancreatic Cancer Research and Education Act HR 2049: Ambulatory Surgical Center Access Act of 2009 S 717: The 21st Century Cancer Alert S 981: Inflammatory Bowel Disease Research Enhancement Act S 254 & HR 574: The Medicare Home Infusion Therapy Coverage Act Increased CDC/FDA funding Food Safety Bill

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of the bill to increase access to home-infusion coverage for Medicare beneficiaries. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for increased Medicare reimbursement for immunosuppressive drugs & for passage of bills. H.R. 4494, The Medicare and Medicaid Extenders Act - Lobbied for passage of the bill to prevent cuts to the Medicare Physician Reimbursement formula (SGR).

Client expense: $384,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of

H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009

Client expense: $280,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

DME Competitive Bidding H.R. 5597: To establish a Medicare patient IVIG access demonstration project H.R. 574: Medicare Home Infusion Therapy Coverage Act of 2009

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Home Oxygen Reimbursement Home Infusion Reimbursement S. 254/H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 DME Competitive Bidding

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3790: Medicare Competitive Bidding for DMEPOS S. 254/H.R. 574: Medicare Home Infusion Therapy Coverage Act of 2009

Client expense: $120,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage Issues H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009 H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) P.L. 111-148 Patient Protection and Affordable Care Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010 S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals S. Amdt. (Baucus) to H.R. 4849 Small Business and Infrastructure Jobs Tax Act of 2010 (340B Provisions) H.R. 1586 Education Jobs and Medicaid Funding Bill (AMP Revisions) H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions and "Pay to Delay" Provision) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital and "Pay to Delay" Provisions) S. 3677 Financial Services and General Government Appropriations Act, 2011 (Pay to Delay Provision) S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011(Infectious Disease Provisions)

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)

healthcare reform; healthcare regulations; Medicare Part D; proposed antitrust exemptions for certain pharmacies; IVIG payments; Medicare Demonstration Projects for durable medical equipment; importation of prescription drugs; home infusion; disclosure of PBM information; changes to drug benefits offered under the FEHBP and increasing healthcare value H.R. 574 and S. 254 - Medicare Home Infusion Therapy Coverage Act of 2009; all sections H.R. 1204 - Community Pharmacy Fairness Act of 2009; all sections H.R. 1765 - To Amend Title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program; all sections H.R. 5597 - To Establish a Medciare Patient IVIG Access Demonstration Project; all sections H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009; all sections H.R. 3962 - Affordable Healthcare for All America Act; all setions S. 1793 - America's Health Future Act of 2009; all sections H.R. 4752 - Medicare Prescription Drug Price Negotiations Act of 2010; all sections Public Law 111-152 - Healthcare and Education Reconciliation Act of 2010 (formerly H.R. 4872); all sections

Client expense: $960,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), Postal Regulatory Commission, SENATE

H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009

Client expense: $260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 574, Medicare Home Infusion Therapy Coverage Act of 2009. A bill to amend title XVIII of the Social Security Act to provide for the coverage of home infusion therapy under the Medicare Program. S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. A bill to amend title XVIII of the Social Security Act to provide for the coverage of home infusion therapy under the Medicare Program.

Client expense: $47,451 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

HR 574/S 254 Medicare Home Infusion Therapy Coverage Act

Client expense: $140,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3590- the "Patient Protection and Affordable Care Act" regarding the role of pharmacists and the practice of pharmacy in healthcare. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1586- the "FAA Air Transportation Modernization and Safety Improvement Act" -Title II- all provisions relating to State Fiscal Relief and other provisions. Extend through the first three quarters of 2011 the Federal Medicaid Assistance Percentage (FMAP). Amend title XIX of the Social Security Act to include Medicaid coverage in the Medicaid average manufacturer price any drug that is an inhalation, infusion, instilled, implanted, or injectable drug that is not generally dispensed through a retail pharmacy. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 5597 - all provisions regarding establishing a Medicare patient IVIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP).

Client expense: $340,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage Issues H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009 H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) - changes to the 340B Drug Discount Program. P.L. 111-148 Patient Protection and Affordable Care Act (PPACA) - funding of PPACA programs and provisions P.L. 111-152 Health Care and Education Reconciliation Act of 2010 S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals S. Amdt. (Baucus) to H.R. 4849 Small Business and Infrastructure Jobs Tax Act of 2010 (340B Provisions) H.R. 1586 Education Jobs and Medicaid Funding Bill (Average Manufacturer Price - AMP Revisions) H.R. 4899 Supplemental Appropriations Act, 2010 (Average Manufacturer Price - AMP Revisions and "Pay to Delay" Provision) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital and "Pay to Delay" Provisions) S. 3677 Financial Services and General Government Appropriations Act, 2011 (Pay to Delay Provision) S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011(Infectious Disease Provisions)

Client expense: $220,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)

DME Competitive Bidding H.R. 5597: To establish a Medicare patient IVIG access demonstration project H.R. 574: Medicare Home Infusion Therapy Coverage Act of 2009

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Home Oxygen Reimbursement Home Infusion Reimbursement S. 254/H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 DME Competitive Bidding

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of bill. H.R. 1485 and S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for passage of bills.

Client expense: $795,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of

Issues related to hospital readmissions/bundling and home infusion therapy coverage, (the Medicare Home Infusion Therapy Coverage Act of 2009 (HR 574/S 254)) The Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565) Issues related to Medicare physician payment system (to amend title XVIII of the Social Security Act to continue using 2009 Medicare practice expense relative value units for certain cardiology services, (HR 4371)), and CPT codes for myocardial perfusion imaging. The Health Care and Education Reconciliation Act of 2010 (HR 4872), the Patient Protection and Affordable Care (HR 3590), and the Affordable Health Care for America Act (HR 3962). Issues related to oncology coverage and medicare clinical trials (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844)).

Client expense: $310,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to hospital readmissions/bundling and home infusion therapy coverage, (the Medicare Home Infusion Therapy CoverageAct of 2009 (HR 574/S 254)) The Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565) Issues related to Medicare physician payment system (to amend title XVIII of the Social Security Act to continue using 2009 Medicare practice expense relative value units for certain cardiology services, (HR 4371)), and CPT codes for myocardial perfusion imaging. The Health Care and Education Reconciliation Act of 2010 (HR 4872), the Patient Protection and Affordable Care (HR 3590), and the Affordable Health Care for America Act (HR 3962). Issues related to oncology coverage and medicare clinical trials, the 21st Century Cancer ALERT ("Access to Life-Saving Early detection, Research and Treatment" Act (HR1844)).

Client expense: $560,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.574 & S.254, The Medicare Home Infusion Therapy Coverage Act of 2009, establishing reimbursement for home infusion therapy services. H.R. 3790, repeal the Medicare competitive acquisition program for durable medical equipment (DMEPOS).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1128: Liver Research Enhancement Act HR 1189: Colorectal Cancer Prevention, Early Detection and Treatment Act HR 745: Pancreatic Cancer Research and Education Act HR 2049: Ambulatory Surgical Center Access Act of 2009 S 717: The 21st Century Cancer Alert S 981: Inflammatory Bowel Disease Research Enhancement Act S 254 & HR 574: The Medicare Home Infusion Therapy Coverage Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3790: Medicare Competitive Bidding for DMEPOS S. 254/H.R. 574: Medicare Home Infusion Therapy Coverage Act of 2009 H.R. 5597: To establish a Medicare patient IVIG access demonstration project H.R. 3590: Patient Protection and Affordable Care Act (PPACA)

Client expense: $170,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Home Oxygen Reimbursement Home Infusion Reimbursement S. 254/H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 DME Competitive Bidding

Client expense: Not reported · Firm income: $30,000

Government targets: SENATE

H.R. 574, Medicare Home Infusion Therapy Coverage Act of 2009. A bill to amend title XVIII of the Social Security Act to provide for the coverage of home infusion therapy under the Medicare Program. S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. A bill to amend title XVIII of the Social Security Act to provide for the coverage of home infusion therapy under the Medicare Program.

Client expense: $45,360 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

health care ceform, health care regulations, Medicare Part D, proposed antitrust exemptions for certain pharmacists, IVIG payments, Medicare Demonstration Projects for durable medical equipment, importation of prescription drugs, home infusion, disclosure of PBM information, changes to drug benefits offered under the FEHBP and increasing healthcare value. H.R. 574 and S. 254 - Medicare Home Infusion Therapy Coverage Act of 2009; all sections H.R. 1204 - Community Pharmacy Fairness Act of 2009; all sections H.R. 1765 - To Amend Title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program; all sections H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009; all sections H.R. 3962 - Affordable Health Care for America Act; all sections S 1793 - America's Healthy Future Act of 2009; all sections H.R. 4752 - Medicare Prescription Drug Price Negotiations Act of 2010; all sections Public Law 111-152 - Health Care and Education Reconciliation Act of 2010 (formerly H.R. 4872); all sections

Client expense: $600,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009

Client expense: $320,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009

Client expense: $400,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Issues pertaining to community and hospital acquired infections (HAC).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Incentives for companies to develop anti-biotics/anti-infectives with FDA priority reveiw voucher. Issues pertaining to community and hospital acquired infections (HAC). 340b program. Biosimilars. H.R. 2400, the Strategies to Address Antimicrobial Resistance Act. H.R.4213, American Jobs and Closing Tax Loopholes Act of 2010: 340b provisions.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 4851, the "Continuing Extension Act of 2010," - section 4 - provisions relating to amending title XVIII (Medicare) of the Social Security Act to extend through May 31, 2010, the 0% update to the conversion factor in the Medicare physician payment computation. HR 5597 - all provisions regarding establishing a Medicare patient NIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP). HR 3590 - the Patient Protection and Affordable Care Act.

Client expense: $350,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

S. 254 Medicare Home Infusion Therapy Coverage Act H.R. 574

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage Issues H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 4213 American Jobs and Closing Tax Loopholes Act of 2010 H.R. 2847 Hiring Incentives to Restore Employment Act H.R. 4851 Continuing Extension Act of 2010 H.R. 3962 Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010

Client expense: $160,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R.574 & S.254, The Medicare Home Infusion Therapy Coverage Act of 2009, establishing reimbursement for home infusion therapy services. H.R. 3790, repeal the Medicare competitive acquisition program for durable medical equipment (DMEPOS).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to hospital readmissions/bundling and home infusion therapy coverage, (the Medicare Home Infusion Therapy Coverage Act of 2009 (HR 574/S 254)) The Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565) Issues related to Medicare physician payment system (to amend title XVIII of the Social Security Act to continue using 2009 Medicare practice expense relative value units for certain cardiology services, (HR 4371)), and CPT codes for myocardial perfusion imaging. The Health Care and Education Reconciliation Act of 2010 (HR 4872), the Patient Protection and Affordable Care (HR 3590), and the Affordable Health Care for America Act (HR 3962). Issues related to oncology coverage and medicare clinical trials (the Comprehensive Cancer Care Improvement Act of 2009 (HR 1844)).

Client expense: $430,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE